Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML.
Blood Adv
; 5(23): 5258-5268, 2021 12 14.
Article
in En
| MEDLINE
| ID: mdl-34625784
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Hematopoietic Stem Cell Transplantation
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Aspects:
Patient_preference
Limits:
Adolescent
/
Adult
/
Humans
/
Middle aged
Language:
En
Journal:
Blood Adv
Year:
2021
Document type:
Article